FDA approves colon cancer drug combo
WASHINGTON, Jan. 23 (UPI) -- The U.S. Food and Drug Administration says it approved a new use of Avastin in combination with oxaliplatin chemotherapy for those colorectal cancer.
Tags:
FDA approves colon cancer drug combo,
Food And Drug Administration Latest News